EUVIMEDEUVIMED entdecken
Open Access

Characterization of m6A Modifiers and RNA Modifications in Uterine Fibroids

Jitu W George iD, Rosa A Cancino, Jennifer L Griffin Miller, Fang Qiu, Qishan Lin, M Jordan Rowley, Varghese M Chennathukuzhi, John S Davis iD

Endocrinology · 2024

DOI: 10.1210/endocr/bqae074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, 2024. Verfasst von Jitu W George und 7 weiteren Autor:innen. Beteiligte Einrichtung: Olson Center for Women's Health, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE 68198, USA. Hauptthemen laut MEDLINE: Leiomyoma, Adenosine, Uterine Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, VA, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uterine leiomyoma or fibroids are prevalent noncancerous tumors of the uterine muscle layer, yet their origin and development remain poorly understood. We analyzed RNA expression profiles of 15 epigenetic mediators in uterine fibroids compared to myometrium using publicly available RNA sequencing (RNA-seq) data. To validate our findings, we performed RT-qPCR on a separate cohort of uterine fibroids targeting these modifiers confirming our RNA-seq data. We then examined protein profiles of key N6-methyladenosine (m6A) modifiers in fibroids and their matched myometrium, showing no significant differences in concordance with our RNA expression profiles. To determine RNA modification abundance, mRNA and small RNA from fibroids and matched myometrium were analyzed by ultra-high performance liquid chromatography-mass spectrometry identifying prevalent m6A and 11 other known modifiers. However, no aberrant expression in fibroids was detected. We then mined a previously published dataset and identified differential expression of m6A modifiers that were specific to fibroid genetic subtype. Our analysis also identified m6A consensus motifs on genes previously identified to be dysregulated in uterine fibroids. Overall, using state-of-the-art mass spectrometry, RNA expression, and protein profiles, we characterized and identified differentially expressed m6A modifiers in relation to driver mutations. Despite the use of several different approaches, we identified limited differential expression of RNA modifiers and associated modifications in uterine fibroids. However, considering the highly heterogenous genomic and cellular nature of fibroids, and the possible contribution of single molecule m6A modifications to fibroid pathology, there is a need for greater in-depth characterization of m6A marks and modifiers in a larger and diverse patient cohort.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeiomyomaAdenosineUterine NeoplasmsHumansFemaleMyometriumMiddle AgedAdultRNA, MessengerRNARNA Processing, Post-TranscriptionalEpigenesis, Genetic

Stichwörter der Autor:innen

epitranscriptomicsraceuterine fibroids

Substanzen

AdenosineN-methyladenosineRNA, MessengerRNA

Autor:innen und Institutionen

  • Olson Center for Women's Health, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Veterans Affairs Nebraska Western Iowa Health Care System, Omaha, NE 68105, USA.
  • Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • RNA Epitranscriptomics and Proteomics Resource, Department of Chemistry, University at Albany, Albany, NY 12222, USA.
  • Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA.

ORCID-Profile: Jitu W George, John S Davis

Förderung

  • NICHD NIH HHS
  • VA
  • NIGMS NIH HHS
  • NIH National Institute of General Medical Sciences
  • Olson Center for Women's Health
  • VA Senior Research Career Scientist Award
  • SRI and Bayer Discovery/Innovation Grant
  • National Institutes of Health (NIH)/NIGMS

Zitieren

APA

George, J. W., Cancino, R. A., Griffin Miller, J. L., Qiu, F., Lin, Q., Rowley, M. J., Chennathukuzhi, V. M., & Davis, J. S. (2024). Characterization of m6A Modifiers and RNA Modifications in Uterine Fibroids. Endocrinology. https://doi.org/10.1210/endocr/bqae074

Vancouver

George JW, Cancino RA, Griffin Miller JL, Qiu F, Lin Q, Rowley MJ, et al. Characterization of m6A Modifiers and RNA Modifications in Uterine Fibroids. Endocrinology. 2024. doi:10.1210/endocr/bqae074

BibTeX
@article{George2024,
  author = {George, Jitu W and Cancino, Rosa A and Griffin Miller, Jennifer L and Qiu, Fang and Lin, Qishan and Rowley, M Jordan and Chennathukuzhi, Varghese M and Davis, John S},
  title = {Characterization of m6A Modifiers and RNA Modifications in Uterine Fibroids},
  journal = {Endocrinology},
  year = {2024},
  doi = {10.1210/endocr/bqae074}
}
Kostenlos starten →